ITEMS OF INTEREST TO THE IMAGING RESEARCH COMMUNITY:
CIP Web Site: http://www.cancer.gov/bip
- BIOMEDICAL IMAGING RESEARCH OPPORTUNITIES WORKSHOP, January 31 - February 1, 2003, Hyatt Regency, Bethesda, MD; Sponsored by: AAPM, ARR, BMES, and RSNA
- FOURTH NATIONAL FORUM ON BIOMEDICAL IMAGING IN ONCOLOGY, sponsored by the NCI, February 6-7, 2003, Hyatt Regency Bethesda, Bethesda, Maryland
- PIE Medical Imaging Meeting. February 15-20, 2003, San Diego, California
- A RE-ISSUE, EARLY CLINICAL TRIALS OF IMAGING AGENTS (NCI) CONTRACT SOLICITATION RFP
Solicitation number: N01-CM-37008
The Cancer Imaging Program (CIP), Division of Cancer Diagnosis and Treatment (DCTD), National Cancer Institute (NCI) is reissuing this RFP to develop contracts to support Phase 1(Safety) and Phase 2(Preliminary Clinical Efficacy) clinical trials of promising imaging agents. These clinical trials will be used to rapidly evaluate the safety and diagnostic imaging capabilities of promising imaging probes, ligands, radiopharmaceuticals, and contrast agents that are of interest to NCI. The Safety and Preliminary Clinical Efficacy Imaging Clinical Trials contracts will create an infrastructure poised to rapidly evaluate molecularly-targeted imaging agents used to assess therapeutic anticancer agents on their molecular targets and determine clinically relevant correlates. The objectives of this program are: to rapidly conduct clinical trials necessary to assess the safety of promising imaging agents; to rapidly conduct clinical trials necessary to assess the diagnostic imaging capabilities and preliminary efficacy of promising imaging agent to characterize the molecular interactions of new molecular imaging agents with their targets through biopsies, assays, and other appropriate technologies and correlate those effects with clinically-relevant endpoints; to develop new scientific insights into molecular pathways and determinants of the relationship of the targeted imaging agents to therapeutic drug response.
URL for NIH Guide Notice: http://grants1.nih.gov/grants/guide/notice-files/NOT-CA-03-006.html
URL: http://www.eps.gov/spg/HHS/NIH/RCB/N01-CM-37008/listing.html (Must use Adobe 5.0 or better)
- CHANGE OF RECEIPT DATE FOR NETWORK FOR TRANSLATIONAL RESEARCH: OPTICAL IMAGING (NCI) (RFA-CA-03-002) (NOT-CA-03-004)
The National Cancer Institute wishes to give notice of a 1-month change of the receipt date for applications submitted in response to RFA CA-03-002, NETWORK FOR TRANSLATIONAL RESEARCH: OPTICAL IMAGING. The previous application receipt date of January 21, 2003 has been changed to February 21, 2003. The Letter of Intent Date is unchanged. All other aspects of this RFA remain unchanged. This RFA appeared in the August 27, 2002 issue of the NIH Guide for Grants and Contracts,
- NIH EXTRAMURAL LOAN REPAYMENT PROGRAM REGARDING CLINICAL RESEARCHERS (NOT-OD-03-012)
The NIH announces the extension of the deadline for the 2003 Extramural Loan Repayment Program for Clinical Researchers (LRP-CR). This year's program is not limited to NIH grantees as was the fiscal year 2002 requirement. The new deadline is now January 31, 2003.
- NCRR SHARED INSTRUMENTATION GRANT (NCRR) (RFA-RR-03-002)
The purpose of this Request for Applications (RFA) is to continue the competitive National Center for Research Resources (NCRR) Shared Instrumentation Grant (SIG) Program. The objective of the program is to make available to institutions expensive research instruments that can only be justified on a shared-use basis and for which meritorious research projects are described.
- IMAGE-GUIDED INTERVENTIONS (NIBIB) (EB-03-008)
APPLICATION RECEIPT DATE: March 25, 2003
NIBIB invites applications for NIH Research Project Grant (R01) awards to support interdisciplinary basic research or Exploratory/Developmental Research (R21) awards that support novel investigations in image-guided interventions. The primary purpose of this Request for Applications (RFA) is to support research and development for image-guided interventions, including biopsies, surgery, and image-guided therapies. This initiative is intended to drive the development of new technology in areas related to image-guided interventions because of the need for minimally invasive, image-guided treatment of disease and injury. Applications are expected to describe how image-guided interventions will benefit from the proposed technology or research.
- EXTRAMURAL RESEARCH FACILITIES IMPROVEMENT PROGRAM PROJECTS (NCRR) (PA-03-040)
Application Receipt Date: February 1, 2003 The principal objective of this program is to facilitate and enhance the conduct of PHS-supported biomedical and behavioral research by supporting the costs of designing and constructing non-Federal basic and clinical research facilities to meet the biomedical or behavioral research, research training, or research support needs of an institution or a research area at an institution.
- CHARLES D. CORYELL AWARD, AMERICAN CHEMICAL SOCIETY DIVISION OF NUCLEAR CHEMISTRY AND TECHNOLOGY
Deadline: January 10, 2003
Every year the Division of Nuclear Chemistry and Technology sponsors the Charles D. Coryell Award for Undergraduate Research in Nuclear Chemistry, for research in the broadly-defined field that is nuclear chemistry. The application process is relatively easy if the research has already been done.
- SUMMER SCHOOL IN NUCLEAR AND RADIOCHEMISTRY FOR UNDERGRADUATES, AMERICAL CHEMICAL SOCIETY (ACS)
Deadline: February 1, 2003
The ACS seeks curious and highly motivated students with strong science backgrounds. If selected, these students receive an all-expense paid opportunity to complete a 6 week summer course in Nuclear and Radiochemistry in either CA or NY. They also earn 6 hours (tuition paid) of undergraduate chemistry credit through either San Jose State University or SUNY-Stoney Brook.
The Cancer Imaging Program at NCI has created this e-mail distribution list to notify interested people about funding opportunities and other issues related to imaging research. Its primary purpose is to call your attention to important, relevant information on NIH Web pages, or in the NIH Guide. Occasionally it may be used to clarify areas of confusion, or disseminate answers to frequently asked questions.
If you wish to remain on the list, no action is necessary. If you wish to be added to the list (or removed from it), please contact Ms. Johnnie Smith by return e-mail (email@example.com).
Cancer Imaging Program
Division of Cancer Treatment and Diagnosis, NCI
EPN, Room 6000 - MSC-7412
6130 Executive Boulevard
Bethesda, MD 20892-7412
Tel: 301 496 9531
Fax: 301 480 3507